Antimicrobial Susceptibility, QC, and Postanalytic Reporting
Key Takeaways
- Routine AST starts with a clinically significant, usually pure isolate and a standardized inoculum, not mixed flora or obvious contaminants.
- Disk diffusion uses Mueller-Hinton agar and a 0.5 McFarland inoculum for many routine bacteria; zones or MICs must be interpreted with current laboratory-approved breakpoints.
- Out-of-range AST quality control is a stop-and-troubleshoot event; affected patient susceptibility results should not be reported until QC problems are resolved according to policy.
- Resistance mechanisms such as beta-lactamase, ESBL, carbapenemase, mecA-mediated MRSA, vanA or vanB VRE, and inducible clindamycin resistance are tested phenotypically or genetically depending on the workflow.
- Postanalytic microbiology includes critical result communication, documentation, corrected reports, infection prevention notification, public health reporting, and suppression of misleading antibiotic results.
Susceptibility Testing Is a Controlled Measurement
Antimicrobial susceptibility testing is not just placing antibiotic disks on a plate. It is a controlled test that begins with the right isolate, a standardized inoculum, approved media, correct incubation, current interpretive criteria, and acceptable quality control. On the ASCP MLT exam, AST questions often test whether you know when not to report.
Routine AST Setup Checklist
| Step | Correct bench reasoning | Common error tested |
|---|---|---|
| Isolate selection | Use a clinically significant, pure isolate when routine AST is indicated | Testing mixed flora or a likely contaminant without workup context |
| Inoculum | Adjust to a 0.5 McFarland standard for many routine disk diffusion methods | Heavy or light inoculum causing false resistance or susceptibility |
| Medium | Mueller-Hinton agar for routine Kirby-Bauer disk diffusion, with special formulations when required | Using blood agar, Sabouraud, or random media for routine disk diffusion |
| Disk or panel | Use in-date materials stored correctly | Expired disks or panels can produce invalid results |
| Incubation | Follow organism-specific time, temperature, and atmosphere | Incubating in the wrong atmosphere or reading too early or late |
| Interpretation | Use current CLSI, FDA, or laboratory-adopted breakpoints according to policy | Applying outdated or manually invented breakpoints |
| QC | Verify control strains are within expected range | Reporting patient AST when affected QC is out of range |
What S, I, and R Mean at the Bench
Susceptible, intermediate, susceptible-dose dependent, and resistant categories are interpretive categories, not raw measurements. A zone diameter or MIC becomes clinically useful only after it is interpreted with an approved breakpoint for that organism and drug combination. The same MIC may not mean the same thing for every organism.
A bench answer should also respect intrinsic resistance. If an organism is intrinsically resistant to an antimicrobial, the lab should not report that agent as susceptible just because an instrument generated a number. Many laboratories suppress misleading agents, use cascade reporting, and require review of unusual phenotypes.
Resistance Mechanism Table
| Resistance clue | Common test or result pattern | Reporting idea |
|---|---|---|
| MRSA | mecA or PBP2a detection, or cefoxitin screen depending on SOP | Report as methicillin-resistant Staphylococcus aureus and follow beta-lactam reporting rules |
| VRE | vanA or vanB detection, or phenotypic vancomycin resistance | Important for infection prevention and isolation decisions |
| ESBL | Phenotypic or molecular detection in Enterobacterales depending on workflow | May alter cephalosporin reporting under current policy |
| Carbapenemase | Phenotypic carbapenemase test or genes such as blaKPC | Often requires confirmation, infection prevention, and sometimes public health action |
| Beta-lactamase | Rapid beta-lactamase test in selected organisms | Can explain penicillin or ampicillin resistance patterns |
| Inducible clindamycin resistance | D-test with erythromycin and clindamycin disks; D-shaped blunting near erythromycin | Report clindamycin resistant when inducible resistance is detected |
QC Failure Decision Tree
- Is the control strain result within the expected range?
- If yes, continue interpretation if all other acceptance criteria are met.
- If no, stop affected reporting and determine the scope of the problem.
- Check inoculum density, purity, media depth, pH, cation content, disk potency, panel storage, incubation conditions, and reader or instrument performance.
- Repeat QC or testing according to SOP.
- Release patient AST only when the QC issue is resolved and policy permits reporting.
Postanalytic Reporting
Postanalytic microbiology is a patient-safety phase. A positive blood culture Gram stain is commonly an urgent preliminary report because it can change therapy before final identification and susceptibility are complete. The report should include the preliminary Gram result as allowed by policy, the notification time, the person notified, and documentation.
Result review asks whether the report makes clinical and microbiologic sense. Do not issue susceptibility results on mixed normal flora as though there is a single pathogen. Do not hide a critical Gram stain while waiting for final ID. Do not leave an incorrect organism or susceptibility report uncorrected; corrected reports must be issued and documented according to policy.
Some results require infection prevention or public health notification. Examples include multidrug-resistant organisms, possible select agents, clusters, or reportable pathogens. The MLT role is to recognize the trigger, follow SOP, document communication, and avoid unsupported interpretation beyond the laboratory result.
Final AST Reporting Checklist
Before releasing susceptibility results, ask these questions: Is the isolate clinically significant? Is the culture pure enough for valid testing? Did QC pass? Are current breakpoints applied? Are intrinsic resistance and suppression rules addressed? Are unusual phenotypes reviewed? Are critical or preliminary results communicated and documented? If any answer is no, the safest exam choice is usually to troubleshoot, hold, confirm, or escalate rather than report blindly.
For routine Kirby-Bauer disk diffusion testing of many common bacteria, which setup is most appropriate?
Daily AST QC for a control strain is outside the acceptable range. What is the best action?
Select all postanalytic or AST reporting practices that are appropriate.
Select all that apply